APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 66 filers reported holding APREA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $21,000 | 0.0% | 4,191 | +0.3% | 0.00% | – |
| Q4 2020 | $21,000 | -79.6% | 4,180 | -2.8% | 0.00% | – |
| Q3 2020 | $103,000 | -39.8% | 4,299 | -2.3% | 0.00% | -100.0% |
| Q2 2020 | $171,000 | +28.6% | 4,398 | +15.0% | 0.00% | 0.0% |
| Q1 2020 | $133,000 | -28.5% | 3,824 | -5.4% | 0.00% | 0.0% |
| Q4 2019 | $186,000 | – | 4,043 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,259,662 | $6,437,000 | 2.66% |
| COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $214,000 | 0.30% |
| Redmile Group, LLC | 694,918 | $3,551,000 | 0.06% |
| Quantamental Technologies LLC | 13,752 | $70,000 | 0.05% |
| KENNEDY CAPITAL MANAGEMENT LLC | 342,486 | $1,750,000 | 0.04% |
| PDT Partners, LLC | 87,734 | $448,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $383,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,100 | $251,000 | 0.01% |
| NEXT Financial Group, Inc | 11,347 | $58,000 | 0.01% |
| Sugarloaf Wealth Management, LLC | 1,500 | $8,000 | 0.00% |